CoChat
Sign Up
Cited by 323

The DOI matches its Crossref record.

Lipoprotein(a) Levels in Familial Hypercholesterolemia

Alonso, Rodrigo, Andres, Eduardo, Mata, Nelva, Fuentes-Jiménez, Francisco, Badimón, Lina, López-Miranda, José, Padró, Teresa, Muñiz, Ovidio, Díaz-Díaz, Jose Luis, Mauri, Marta, Ordovás, Jose María, Mata, Pedro·2014·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2014.01.063
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2014.01.063

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 25

  1. Slack, 1969, Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states, Lancet, 2, 1380, 10.1016/S0140-6736(69)90930-1 · DOI
  2. Alonso, 2002, Heterozygous familial hypercholesterolemia in Spain. Description of 819 non related cases, Med Clin (Barc), 118, 487, 10.1016/S0025-7753(02)72428-7 · DOI
  3. 1991, The risk of fatal coronary heart disease in familial hypercholesterolemia, BMJ, 3030, 893
  4. Jansen, 2004, The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients, J Intern Med, 256, 482, 10.1111/j.1365-2796.2004.01405.x · DOI
  5. Nordestgaard, 2010, European Atherosclerosis Society Consensus Panel. Lipoprotein(a) as a cardiovascular risk factor: current status, Eur Heart J, 31, 2844, 10.1093/eurheartj/ehq386 · DOI · Paper page
  6. Erqou, 2009, Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality, JAMA, 302, 412, 10.1001/jama.2009.1063 · DOI · Paper page
  7. Kamstrup, 2008, Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study, Circulation, 117, 176, 10.1161/CIRCULATIONAHA.107.715698 · DOI
  8. Seed, 1990, Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia, N Engl J Med, 322, 1494, 10.1056/NEJM199005243222104 · DOI
  9. de Sauvage Nolting, 2003, Prevalence and significance of cardiovascular risk factors in a large cohort of patients with familial hypercholesterolaemia, J Intern Med, 253, 161, 10.1046/j.1365-2796.2003.01070.x · DOI
  10. Hopkins, 2001, Evaluation of coronary risk factors in patients with heterozygous familial hypercholesterolemia, Am J Cardiol, 87, 547, 10.1016/S0002-9149(00)01429-6 · DOI
  11. Holmes, 2005, Lipoprotein(a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia, Clin Chem, 51, 2067, 10.1373/clinchem.2005.055228 · DOI
  12. Nenseter, 2011, Lipoprotein(a) levels in coronary heart disease-susceptible and -resistant patients with familial hypercholesterolemia, Atherosclerosis, 216, 426, 10.1016/j.atherosclerosis.2011.02.007 · DOI
  13. Mata, 2011, Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART), Lipids Health Dis, 10, 94, 10.1186/1476-511X-10-94 · DOI
  14. Alonso, 2009, Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platform, Clin Biochem, 42, 899, 10.1016/j.clinbiochem.2009.01.017 · DOI
  15. Simó, 2003, Evaluation of a fully-automated particle-enhanced turbidimetric immunoassay for the measurement of plasma lipoprotein(a). Population-based reference values in an area with low incidence of cardiovascular disease, Clin Biochem, 36, 129, 10.1016/S0009-9120(02)00416-2 · DOI
  16. Alonso, 2008, Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors, Atherosclerosis, 200, 315, 10.1016/j.atherosclerosis.2007.12.024 · DOI
  17. Wiklund, 1990, Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolemia, Lancet, 335, 1360, 10.1016/0140-6736(90)91242-3 · DOI
  18. Utermann, 1989, Defects in the low density lipoprotein receptor gene affect lipoprotein(a) levels: multiplicative interaction of two loci associated with premature atherosclerosis, Proc Natl Acad Sci U S A, 86, 4171, 10.1073/pnas.86.11.4171 · DOI
  19. Lingenhel, 1998, Concentrations of the atherogenic Lp(a)are elevated in FH, Eur J Hum Genet, 6, 50, 10.1038/sj.ejhg.5200152 · DOI · Paper page
  20. Mbewu, 1991, Serum Lipoprotein(a) in patients heterozygous for familial hypercholesterolemia, their relatives and unrelated control populations, Arterioscler Thromb, 11, 940, 10.1161/01.ATV.11.4.940 · DOI
  21. Leitersdorf, 1991, Diverse effect of ethnicity on plasma lipoprotein (a) levels in heterozygous patients with familial hypercholesterolemia, J Lipid Res, 32, 1513, 10.1016/S0022-2275(20)41918-2 · DOI
  22. Kraft, 2000, Lipoprotein(a) in homozygous familial hypercholesterolemia, Arterioscler Thromb Vasc Biol, 20, 522, 10.1161/01.ATV.20.2.522 · DOI · Paper page
  23. Thompson, 2008, Recommendations for the use of LDL apheresis, Atherosclerosis, 198, 247, 10.1016/j.atherosclerosis.2008.02.009 · DOI
  24. Alonso, 2013, Early diagnosis and treatment of familial hypercholesterolemia: improving patient outcomes, Expert Rev Cardiovasc Ther, 11, 327, 10.1586/erc.13.7 · DOI
  25. Tsimikas, 2012, Lipoprotein(a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop targeted therapies, J Am Coll Cardiol, 60, 716, 10.1016/j.jacc.2012.04.038 · DOI

Cited by

Sorted by citations

Metadata

Authors
Alonso, R., Andres, E., Mata, N., Fuentes-Jiménez, F., Badimón, L., López-Miranda, J., Padró, T., Muñiz, O., Díaz-Díaz, J. L., Mauri, M., Ordovás, J. M., & Mata, P.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2014-05
Volume
63
Issue
19
Pages
1982-1989
ISSN
0735-1097
DOI
10.1016/j.jacc.2014.01.063
Cited by
323
References
0
Language
en
Licence
Funders
  • Familial Hypercholesterolemia Foundation (G03/101)
  • Instituto de Salud Carlos III (FIS PI12/01289)
  • Centro Nacional de Investigación Cardiovascular (08-2008)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review